Wednesday, October 18, 3:00pm - 4:00pm (EDT)
Time zone
am/pm
24h
Suggestions
Your search did not return any results.
Zoom Link
Dr. Antal’s laboratory uses a multidisciplinary approach to investigate the molecular underpinnings of pancreatic cancer progression, including epigenomics, high-throughput CRISPR and DNA base editing screens, computational approaches, and mouse models of pancreatic cancer. Learn more about her research.
You're going to "CBS Seminar | Elucidating epigenetic and RNA processing dysregulation in pancreatic cancer".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
You're interested in "CBS Seminar | Elucidating epigenetic and RNA processing dysregulation in pancreatic cancer".
We've sent a confirmation email to your email address. Be sure to check your junk folder in case you haven't received the confirmation.
Thank you!
Your changes have been saved. Thanks for keeping us updated.
Comer Commons
Cancer Biology & Signaling Program